Alan Meds advertises both a buy-one-get-one promotional structure and a monthly billing plan for compounded semaglutide—but official pages conflict on which offer is current. We normalize both structures to 12-month costs and compare against prepaid alternatives.

Alan Meds' semaglutide pricing shows conflicting official rates; seven verified programs—including PlexusDx at $189 month-to-month—offer transparent, lower ongoing costs for compounded GLP-1 treatment.

Alan Meds advertises compounded semaglutide with conflicting pricing structures: a promotional two-month offer and a first-month-then-refill model. We compare both against PlexusDx's transparent month-to-month and commitment rates.

Alan Meds publishes conflicting semaglutide prices on official pages—one shows a two-month prepaid offer, another lists a first-month rate and higher refill price. We compare both scenarios against PlexusDx's transparent month-to-month and commitment pricing.

Alan Meds advertises two conflicting semaglutide pricing structures on official pages: a two-month prepaid BOGO offer and a first-month-then-refill model. We normalize both against PlexusDx's flat-rate plans to show the true 12-month cost.

Alan Meds displays two conflicting semaglutide price structures on official pages captured the same day: a $315 buy-one-get-one promotion and a $297 first-month/$397 refill plan. We explain both paths, calculate 12-month costs, and compare to PlexusDx's flat-rate model.